Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Braess

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Blood|July 24, 2013
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemiaSabrina Opatz, Harald Polzer, Tobias Herold, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Blood|June 12, 2016
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaKlaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaFriederike Pastore, Annika Dufour, Tobias Benthaus, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Blood|March 26, 2013
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patientsAnnika Dufour, Giuseppe Palermo, Evelyn Zellmeier, et al.
Blood|June 1, 2012
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemiaPhilipp A Greif, Annika Dufour, Nikola P Konstandin, et al.
Leukemia|January 4, 2020
The clinical mutatome of core binding factor leukemiaSabrina Opatz, Stefanos A Bamopoulos, Klaus H Metzeler, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyJan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Blood|July 24, 2013
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemiaSabrina Opatz, Harald Polzer, Tobias Herold, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Blood|June 12, 2016
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaKlaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaFriederike Pastore, Annika Dufour, Tobias Benthaus, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Blood|March 26, 2013
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patientsAnnika Dufour, Giuseppe Palermo, Evelyn Zellmeier, et al.
Blood|June 1, 2012
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemiaPhilipp A Greif, Annika Dufour, Nikola P Konstandin, et al.
Leukemia|January 4, 2020
The clinical mutatome of core binding factor leukemiaSabrina Opatz, Stefanos A Bamopoulos, Klaus H Metzeler, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyJan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Pageof 9